Overview
Dr Judd Moul joined the Duke faculty in mid 2004 after a career in the US Army Medical Corps mainly at Walter Reed Army Medical Center. He is a retired colonel and a noted researcher and clinician in the area of prostate cancer and is a urologic oncologist. He served as the division chief of Duke Division of Urology from 2004 to 2011 and was named the James H Semans MD Professor of surgery in 2009 becoming Duke's first named endowed chair for urology. He was awarded the Gold Cystoscope Award from the American Urologic Association as well as Castle Connelly Physician of the year for Clinical Medicine in 2009. He has performed more than 1300 radical prostatectomies since joining the Duke faculty and is committed to outcomes research on this series and in other areas of prostate cancer. He served as the Editor for Prostate Cancer and Prostatic Dissease, a Nature Medicine journal, for more than a decade and is a popular speaker and lecturer having been visiting professor and keynote speaker throughout the US and the World. He is very committed to training residents and mentoring students and trainees.
Office Hours
Clinic days: 2nd and 4th Mondays, all Tuesdays , Thursday mornings generally from 8am to 5pm
OR Days: 1st, 3rd, 5th Mondays and all Wednesdays
OR Days: 1st, 3rd, 5th Mondays and all Wednesdays
Current Appointments & Affiliations
James H. Semans, M.D. Distinguished Professor of Urologic Surgery, in the School of Medicine
·
2009 - Present
Urology,
Clinical Science Departments
Professor of Urology
·
2005 - Present
Urology,
Clinical Science Departments
Professor in Anesthesiology
·
2012 - Present
Anesthesiology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2004 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence.
Journal Article NPJ Precis Oncol · January 29, 2025 Black men suffer disproportionately from prostate cancer (PCa) compared to men of other races and ethnicities. Comparing the molecular landscape of PCa among Black and White patients has the potential to identify targets for development of new precision me ... Full text Link to item CiteThe Role of Sleep Apnea in Postoperative Neurocognitive Disorders Among Older Noncardiac Surgery Patients: A Prospective Cohort Study.
Journal Article Anesth Analg · January 1, 2025 BACKGROUND: Obstructive sleep apnea is associated with increased dementia risk, yet its role in postoperative neurocognitive disorders is unclear. Here, we studied whether the severity of untreated obstructive sleep apnea is associated with the severity of ... Full text Link to item CiteThe changing face of castrate resistant prostate cancer.
Journal Article Prostate Cancer Prostatic Dis · September 19, 2024 Full text Link to item CiteRecent Grants
A Prospective Trial - Evaluation of ExoDx Prostate in Men with Prostate Cancer in an Active Surveillance Regimen
Clinical TrialPrincipal Investigator · Awarded by Exosome Diagnostics, Inc. · 2022 - 2026Phase III Randomized Efficacy and Safety Study
Clinical TrialPrincipal Investigator · Awarded by Medivation, Inc. · 2016 - 2026NWU22-12-01 A PHASE 2 PLACEBO-CONTROLLED TRIAL OF UROLITHIN A SUPPLEMENTATION IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY
Clinical TrialCo Investigator · Awarded by Northwestern University · 2024 - 2025View All Grants
Education, Training & Certifications
Thomas Jefferson University ·
1982
M.D.
Pennsylvania State University ·
1979
B.S.